Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanocortin Obesity Syndrome”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Post-approval studies (Phase 4)Looking for participantsNCT07674290
What this trial is testing

Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity

Who this might be right for
Bardet Biedl Syndrome (BBS)Bardet Biedl SyndromeBardet-Biedl Syndrome (BBS)+1 more
Tom Hühne 200
Testing effectiveness (Phase 2)Looking for participantsNCT06239116
What this trial is testing

RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Who this might be right for
Hypothalamic ObesityPrader-Willi SyndromePWS
Rhythm Pharmaceuticals, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT03013543
What this trial is testing

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Who this might be right for
Genetic ObesityObesityObesity Due to Melanocortin 4 Receptor Deficiency
Rhythm Pharmaceuticals, Inc. 213
Testing effectiveness (Phase 2)Looking for participantsNCT06899178
What this trial is testing

Atomoxetine in Melanocortin Obesity Syndrome

Who this might be right for
Melanocortin Obesity SyndromeMCOS
Icahn School of Medicine at Mount Sinai 20
Testing effectiveness (Phase 2)Study completedNCT02311673
What this trial is testing

Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome

Who this might be right for
Prader-Willi Syndrome
Rhythm Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06772597
What this trial is testing

Setmelanotide in Patients With Prader-Willi Syndrome

Who this might be right for
Prader-Willi SyndromeObesityHyperphagia
Rhythm Pharmaceuticals, Inc. 18